The role of SGK1 in the development of obesity is underscored by the observation that a variant of the SGK1 gene (the combined presence of distinct polymorphisms in intron 6 [I6CC] and in exon 8 [E8CC/CT]) is associated with increased body weight

The role of SGK1 in the development of obesity is underscored by the observation that a variant of the SGK1 gene (the combined presence of distinct polymorphisms in intron 6 [I6CC] and in exon 8 [E8CC/CT]) is associated with increased body weight. Fibrosis, Hypertension, Inflammation, Metabolic syndrome == 1. Introduction == Theserum- andglucocorticoid-induciblekinase 1 (SGK1) was discovered as a gene regulated transcriptionally by serum- and glucocorticoids in rat mammary tumor cells [1]. The human isoform was cloned as an immediate early gene upregulated by cell shrinkage [2]. SGK1 transcripts are found in virtually all 2-Hydroxy atorvastatin calcium salt tissues, but their level varies between different cell types in brain [3], eye [4], inner ear [57], semicircular canal duct epithelium [6], lung [3,8,9], kidney [10], liver, intestine, pancreas and ovary [4]. Expression patterns depend on the developmental state [4,11]. In humans, the SGK1 encoding gene is localised in chromosome 6q23 [4]. Several translational SGK1 variants have been identified, which differ in regulation of expression, subcellular localization and function [1214]. SGK1 forms dimers by two intermolecular disulfide bonds between Cys258 in the activation loop and Cys193 [15]. SGK1 stimulates a variety of ion channels, transporters, transcription factors and enzymes [4]. The kinase thus participates in the regulation of a wide variety of functions (for earlier reviews see [4,16]). In the present review, the case is made that SGK1 plays a dual role in the pathophysiology of diabetes. At the one hand, it facilitates the development of obesity, which in turn predisposes to the development of type 2 diabetes. On the other hand, it is upregulated by hyperglycemia and contributes to the development of hypertension, excessive coagulation and fibrosis in the affected patients. == 2. Transcriptional SGK1 regulation 2-Hydroxy atorvastatin calcium salt == As evidenced from Northern blotting, RT-PCR and/orin situhybridisation, SGK1 transcription is stimulated by glucocorticoids [1,17], mineralocorticoids [18,19], gonadotropins [4]., progestin [20], progesterone, 1,25-dyhydroxyvitamin D3(1,25(OH)2D3), transforming growth factor (TGF), interleukin 6, fibroblast and platelet-derived growth factor [4], thrombin [21], endothelin [4,22], advanced glycation end products (AGE), further cytokines and activation of peroxisome proliferator-activated receptor [4,23]. Additional stimulators include cell shrinkage [4], excessive glucose concentrations [4], A6 cell swelling [24], chelation of Ca2+[24], metabolic acidosis [25], salt loading of spontaneously hypertensive mice [26], oxidative stress [17,27], heat shock, UV radiation, DNA damage,ischemia, neuronal injury, neuronal excitotoxicity, neuronal challenge by exposure to microgravity, fear conditioning, plus maze exposure, enrichment training, amphetamine, lysergic acid dimethylamide LSD, electroconvulsive therapy, sleep deprivation and fluoxetine [4,28]. Moreover, enhanced SGK1 transcript levels were observed in diabetic nephropathy [29], Rett syndrome, organ rejection, dialysis, wound healing, glomerulonephritis, liver cirrhosis, fibrosing pancreatitis, Crohn’s disease, lung fibrosis and cardiac fibrosis [4,30]. SGK1 transcription is downregulated by heparin, mutations in the gene encoding methyl-CpG-binding protein 2 (MECP2), dietary iron and nucleosides [4,31]. 2-Hydroxy atorvastatin calcium salt Signalling molecules participating in the regulation of SGK1 transcription include cyclic AMP [20], reactive oxygen species and NADPH oxidases [21], protein kinase C, protein kinase Raf, big mitogen-activated protein kinase 1 (BMK1), mitogen-activated protein kinase (MKK1), stress-activated protein kinase-2 (SAPK2, p38 kinase), phosphatidylinositol-(PI)-3-kinase, extracellular signal-regulated kinase (ERK1/2), p53, cytosolic Ca2+, nitric oxide, EWS/NOR1(NR4A3) fusion protein [4,32], The promoter of the rat SGK1 gene contains binding sites Rabbit polyclonal to Akt.an AGC kinase that plays a critical role in controlling the balance between survival and AP0ptosis.Phosphorylated and activated by PDK1 in the PI3 kinase pathway. for several transcription factors including receptors for glucocorticoids (GR), mineralocorticoids (MR), progesterone (PR), the vitamin D receptor (VDR), retinoids (RXR), farnesoids (FXR), as well as sterol regulatory element binding protein (SREBP), peroxysome proliferator activator receptor gamma (PPAR), cAMP response element binding protein (CREB), p53 tumor suppressor protein, Sp1 transcription factor, activating protein 1 (AP1), activating transcription factor 6 (ATF6), heat shock factor (HSF), reticuloendotheliosis viral oncogene homolog (c-Rel), nuclear factor B (NFB), signal transducers and activators of transcription (STAT), TGF dependent transcription factors SMAD3 and SMAD4, and fork-head activin signal transducer (FAST) [1]. == 3. Posttranscriptional localization and regulation of SGK1 == According to immunohistochemistry, serum may trigger importin-alpha mediated entry of SGK1 into the nucleus [4] and hyperosmotic shock or glucocorticoids may increase the cytosolic SGK1 abundance [1,4]..